The final, formatted version of the article will be published soon.
REVIEW article
Front. Med.
Sec. Intensive Care Medicine and Anesthesiology
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1440992
Prokinetic effect of erythromycin in the management of gastroparesis in critically ill patients -our experience and literature review
Provisionally accepted- 1 Other, Gdańsk, Poland
- 2 Department of Anesthesiology and Intensive Care, Copernicus Memorial Hospital in Lodz, Lodz, Poland
- 3 Medical University of Gdansk, Gdańsk, Pomeranian, Poland
- 4 Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszów, Poland
- 5 Institute of Health Sciences, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland
Gastroparesis is a disorder characterized by impaired gastric emptying and the accumulation of food in the intestines without any clear mechanical cause. Gastroparesis in critical care patients is a prevalent issue in the intensive care unit. The disruption of normal gastrointestinal motility in critically ill patients is linked to a significant risk of intolerance to enteral feeding, colonization of the gastrointestinal tract with pathogenic bacterial strains, increased permeability of the intestinal wall, translocation of the intestinal microbiota, leading to progressive malnutrition, and potential development of bacterial infection. Material and methods: The literature was reviewed to assess the benefits and risks associated with the use of this medication. Aim: The aim of the study was to treat the symptoms of gastroparesis and stimulate gastrointestinal motility. Consequently, the aim was to reduce the amount of backed-up food content in the stomach, accelerate gastrointestinal motility, and return to intestinal feeding. Results:Gastroparesis is a frequent issue among patients in the intensive care unit. Critical illness can lead to gastrointestinal motility disorders, causing slowed gastric emptying. This increases the risk of problems such as intolerance to enteral feeding, regurgitation, and aspiration of gastrointestinal contents into the respiratory tract, as well as colonization of the gastrointestinal tract by pathogens. Over time, impaired intestinal absorption can result in malnutrition, necessitating the initiation of parenteral nutrition. Conclusion: After analysis of the literature and published scientific reports, as well as considering their own research, it is evident that erythromycin, as a prokinetic drug, effectively enhances gastrointestinal motility. This contributes to stimulating gastric emptying in critically ill patients with gastroparesis who are hospitalized in an intensive care unit. The use of erythromycin in combination with metoclopramide and/or itopride hydrochloride allows for a synergistic effect, leading to the quickest possible return to enteral feeding.
Keywords: Gastroparesis, Gastrointestinal paralysis, Erythromycin, Critically ill patient, Intensive Care
Received: 30 May 2024; Accepted: 26 Aug 2024.
Copyright: © 2024 Szczupak, Jankowska, Jankowski, Wierzchowska, Kobak, Kosydar-Bochenek and Krupa-Nurcek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mateusz Szczupak, Other, Gdańsk, Poland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.